Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
This research aims to study pediatric participants under 12 years old with influenza to evaluate the prevalence of specific amino acid changes that might affect the viruss susceptibility to baloxavir marboxil. The study includes two parts Part A focuses on surveillance of resistance-associated substitutions before and after treatment, while Part B examines the transmission of influenza from treated children to their household contacts. Enrollment for Part B has stopped as per the latest protocol version. Participants in Part A receive a single oral dose of baloxavir marboxil on the first day, with the dose based on their body weight and age. Household contacts of these participants may be enrolled in Part B but do not receive treatment. The study monitors viral changes and resistance by collecting samples on days 1, 4, 6, and 10, with further assessments up to day 29. The study is open-label and conducted across multiple centers. During the study, participants will be assessed for resistance-associated virus mutations and changes in viral load using laboratory tests including RT-PCR. Household contacts are monitored for influenza transmission and symptoms. Safety is tracked by reporting adverse events during the follow-up period. This trial is expected to continue until mid-2027, with participants involved for up to 29 days after dosing for primary evaluations and extended monitoring of virus resistance and transmission.